Cartoon investor on virtual therapy call with Teladoc, surrounded by dollar signs, loss charts, and hope — symbolizing TDOC’s stock troubles and digital healthcare promise.

Teladoc: Still Waiting for Insiders and Hedge Funds to Swipe Right

Trigger #1: The stock just gained 20% 📈 in decent volume. 🩺 💔
Trigger #2: We had an epiphany about TDOC: It's hard to have one at all. 🤷♂️


Teladoc Health ($TDOC, $8.85 +4.00%, as of July 9, 2025) offers virtual healthcare services through brands like Teladoc, Livongo, and BetterHelp. Sounds modern, right? So why does the stock still feel stuck in the waiting room?

Let’s walk you through what’s going on:

🧾 Financial Check-Up

🩹 Revenue (2024): $2.57B, down 1%
💸 Net Loss (2024): $1.001B, or -$5.87/share (gulp)
📉 Adjusted EBITDA (2024): $311M, down 5%
💰 Cash Flow (2024): Still positive, but down
💥 Goodwill Impairment: $790M (oof!)
🎁 Stock-Based Comp: $146M — someone's getting paid, just not shareholders 😬

🔮 2025 Forecast:

  • Revenue flat-ish

  • Net loss expected to shrink to between -$1.10 and -$0.50/share

  • Free Cash Flow: $190M–$220M 💪


🚨 First Quarter 2025: Stat!

  • Revenue down 3%

  • Net loss: -$93M

  • Impairment charges keep on coming (another $59M)

  • BetterHelp revenue down 11% — turns out, therapy for a struggling business doesn’t always work

  • Acquisition: UpLift Health — good intentions, unknown outcomes

👉 Want the full picture? Dive into Teladoc's financials here.


📉 So... What’s the Diagnosis?

  1. The top line’s shrinking (not ideal for growth stories) 📉

  2. They keep losing money — and not just a little 💸

  3. The short interest is high (12.4%) — Wall Street’s not convinced 😒

  4. Integration risks from all the acquisitions could mean more write-downs 😬

  5. Insiders? Haven’t been buying. In fact, not even browsing 🙅

  6. Cathie Wood's ARK? Left the building 🚪

💡💡💡 Curious about another deep oil exploration play?
Check our takes on UnitedHealth Group or even Oscar Health.


💡 But Wait — Some Silver Linings?

Institutional support: 74.98% of float owned by funds
Cash flow positive — for now
Reasonable debt-to-equity (1.1)
Cheap valuation:

  • Price/Sales = 0.60

  • EV/Revenue = 0.76

  • Price/Book = 1.09

UpLift acquisition could improve prospects if integrated well 🛠️

🔍 For full Institutional Ownership breakdown, see here


🧠 Final Take: Mental Health, Meet Financial Headache

TDOC might eventually turn the corner… but right now, it’s mostly about waiting. If you must invest, maybe start small and dollar-cost-average in. Or just book a session with BetterHelp to talk about your investing regrets. 🛋️📉

👀 Still waiting for a buy signal from management. (Or at least a therapist's note.)


🚨 Disclaimer:

This is not financial advice. It’s just a second opinion — and yes, we’re billing your sense of humor..


🧭 Want More Like This?

😂 Laugh, Learn, Invest: funanc1al.com | Funanc1al: Where Even Finance Meets Funny

 

Got a thought? A tip? A tale? We’re all ears — drop it below.:

Please note, comments must be approved before they are published